McKesson management check
MCK · Health Care · Health Care Distributors · CEO Brian S. Tyler
Filings as of
Closest peers in Health Care Distributors
- 46CAHCardinal Health81
- 144MCKMcKesson72
- 151DHRDanaher Corporation72
- 153ISRGIntuitive Surgical72
- 268CORCencora63
- 448HSICHenry Schein46
The seven checks
- GoodBeat its chosen peers
Have owners done well?
What $100 became since fiscal 2022
100100thDetail
$100 invested at the start of fiscal 2022 grew to $456, against $137 for the peer group the company picked itself.
- FlagPay moved against returns
Does pay follow performance?
Pay actually paid $100 value, each on its own scale
346thDetail
Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of -0.33 with shareholder return. 1 means pay moved in step; below 0, the opposite way.
- Good0.5% of net income
What does the CEO cost owners?
$24.2m pay · $4.8bn net income, FY2026
7476thDetail
$24.2m of reported pay in fiscal 2026, against $4.8bn of net income.
- WatchCEO stake ≈ 0.2 years of pay
Do they own the stock?
5,919 shares ≈ $4.7m
6 mo: ▲ $0 bought · ▼ $26.1m sold
05thDetail
The CEO holds 5,919 shares, directly or through trusts (unvested awards not counted): about 0.2 years of pay. Light activity: no buys, $26.1m sold in six months. 13 of 14 sales ran on pre-arranged 10b5-1 plans.
- GoodShare count shrinking
Are owners being diluted?
Diluted shares −3.8% a year; flagged above +2%
Stock pay 0.1% of revenue
9886thDetail
Diluted shares changed -3.8% a year over the last three fiscal years. Stock-based pay was 0.1% of revenue in the latest year.
- Good4 leadership filings in 3 years
Is leadership stable?
4 filings under 8-K 5.02 in 3 years
CEO: Brian S. Tyler
100100thDetail
CEO in the pay table: Brian S. Tyler. 4 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.
- GoodNo red flags on file
Are the books clean?
Since 2021
- 0Restated
- 0Auditor changes
- 0Late filings
- 010-K amended
100100thDetail
No restatements, auditor changes or late filings since 2021.
Reading the scores
Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.
Hover a chart for its figures. Detail has the full reading.
Pay versus performance
From the proxy statement filed June 12, 2026.
Pay tied most to Adjusted EPS
Other key measuresAdjusted Operating ProfitFree Cash FlowAverage ROIC
Show the figures
| Fiscal year | CEO | CEO pay | Actually paid | Other executives (avg) | $100 became | Peers | Net income |
|---|---|---|---|---|---|---|---|
| 2026 | Brian S. Tyler | $24.2m | $48.9m | $5.5m | $456 | $137 | $4.8bn |
| 2025 | — | $20.2m | $39.2m | $5.0m | $353 | $134 | $3.3bn |
| 2024 | — | $19.0m | $51.7m | $5.2m | $281 | $133 | $3.0bn |
| 2023 | — | $20.2m | $38.8m | $4.9m | $185 | $115 | $3.6bn |
| 2022 | — | $18.2m | $65.3m | $4.5m | $158 | $119 | $1.1bn |
Insiders and the CEO's stakeQuiet
- Chief Executive Officer
- Brian S. Tyler
- Shares held
- 5,919
- At that filing's price
- ≈ $4.7m
- Latest Form 4
- Jul 7, 2026
Light activity: no buys, $26.1m sold in six months. 13 of 14 sales ran on pre-arranged 10b5-1 plans.
Open-market trades by officers and directors since May 21, 2026.
- SoldBrian S. TylerChief Executive Officer · 10b5-1 plan$17.0mJul 7, 2026
- SoldMichele LauEVP and Chief Legal Officer · 10b5-1 plan$2.7mMay 26, 2026
- SoldThomas L RodgersEVP, Chief Strategy & BDO · 10b5-1 plan$2.4mJun 2, 2026
- SoldFrancisco FragaEVP, CIO and CTO · 10b5-1 plan$2.1mNov 5, 2026
Leadership and governance on file
All 11 filings
- Jul 1, 2026Leadership change8-K 5.02
- Mar 5, 2026Leadership change8-K 5.02
- Jun 3, 2024Leadership change8-K 5.02
- Jan 9, 2024Leadership change8-K 5.02
- Nov 1, 2023Leadership change8-K 5.02
- Oct 3, 2023Leadership change8-K 5.02
- Sep 13, 2022Leadership change8-K 5.02
- Apr 29, 2022Leadership change8-K 5.02
- Apr 1, 2022Leadership change8-K 5.02
- Feb 22, 2022Leadership change8-K 5.02
- Jan 18, 2022Leadership change8-K 5.02
Latest shareholder vote results: Jul 24, 2026, including the say-on-pay vote.
Where the money went
2021–2025: $19.7bn returned to owners in buybacks and dividends, 125% of net income, and $978.0m of pay in stock.
Show the figures
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $264.0bn | $276.7bn | $309.0bn | $359.1bn | $403.4bn |
| Net income | $1.1bn | $3.6bn | $3.0bn | $3.3bn | $4.8bn |
| Stock-based pay | $161.0m | $162.0m | $182.0m | $226.0m | $247.0m |
| Buybacks | $3.5bn | $3.6bn | $3.0bn | $3.1bn | $4.8bn |
| Dividends | $277.0m | $292.0m | $314.0m | $345.0m | $381.0m |
| Diluted shares | 154m | 142m | 134m | 128m | 124m |
Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.